Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: Intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials

Heart

Volumn 94, Issue 3, 2008, Pages 322-328

  Hoffmann, R ^a,j   Morice, M C ^b   Moses, J W ^c   Fitzgerald, P J ^d   Mauri, L ^e   Breithardt, G ^f   Schofer, J ^g   Serruys, P W ^h   Stoll, H P ⁱ   Leon, M B ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^c NewYork Presbyterian Hospital   (United States)

^d STANFORD UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g Ctr Cardiol and Vasc Intervention   (Germany)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ Cordis Clinical Research ^*  (Belgium)

^j RWTH AACHEN UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METAL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; LATE INCOMPLETE STENT APPOSITION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTHESIS FAILURE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; TIME FACTORS; TUBULIN MODULATORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 39749127135     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.120154     Document Type: Article

References (20)

1. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
2. Iakovou I, Schmidt T, Ronizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
3. Pfisterer M, Brunner-La Rocca HP, Suser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91.
4. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-814.
5. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
6. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004;109:881-6.
7. Mintz GS, Shah VM, Weissman NJ. Regional remodeling as the cause of late stent malapposition. Circulation 2003;107:2660-3.
8. Bavry AA, Kumbhani DJ, Helton TJ. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary interventions? J Am Coll Cardiol 2005;45:941-6.
9. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions. Circulation 2003;108:2747-50.
10. Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents. Circulation 2005;111:900-5.
11. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
12. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
13. Morice MC, Serruys PW, Sousa JE, et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
14. Hoffmann R, Guagliumi G, Musumeci G, et al. Vascular response to sirolimus-eluting stents delivered with a non-aggressive implantation technique, intravascular ultrasound analysis from the multicenter, randomized, E-SIRIUS and SIRIUS Trials. Catheter Cardiovasc Interv 2005;64:499-506.
15. Shah VM, Mintz GS, Apple S, et al. Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002;106:1753-5.
16. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation. J Am Coll Cardiol 2005;46:1002-5.
17. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation. Circulation 2006;113:414-9.
18. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial. Circulation 2002;106:798-803.
19. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 2002;23:124-32.
20. Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-97.